Hap Trading, LLC Tyme Technologies, Inc. Put Options Transaction History

Hap Trading, LLC

  • $840 Billion
  • Q2 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 12, 2022
SELL
$0.28 - $0.68 $2,800 - $6,800
-10,000 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$0.6 - $1.04 $1,320 - $2,288
-2,200 Reduced 18.03%
10,000 $15,000
Q3 2021

Nov 10, 2021
BUY
$0.99 - $1.38 $12,078 - $16,836
12,200 New
12,200 $3,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email